nlrp3 e311k mutation in a large family with muckle-wells syndrome - description of a heterogeneous phenotype and response to treatmentnlrp3 e311k突变一个大家庭muckle-wells综合症u2014u2014异构表型的描述和对治疗的反应.pdfVIP

nlrp3 e311k mutation in a large family with muckle-wells syndrome - description of a heterogeneous phenotype and response to treatmentnlrp3 e311k突变一个大家庭muckle-wells综合症u2014u2014异构表型的描述和对治疗的反应.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
nlrp3 e311k mutation in a large family with muckle-wells syndrome - description of a heterogeneous phenotype and response to treatmentnlrp3 e311k突变一个大家庭muckle-wells综合症u2014u2014异构表型的描述和对治疗的反应

Kuemmerle-Deschner et al. Arthritis Research Therapy 2011, 13:R196 /content/13/6/R196 RESEARCH ARTICLE Open Access NLRP3 E311K mutation in a large family with Muckle-Wells syndrome - description of a heterogeneous phenotype and response to treatment 1* 2 3 4 4 Jasmin B Kuemmerle-Deschner , Peter Lohse , Ina Koetter , Guenther E Dannecker , Fabian Reess , 1 3 5 1 6 Katharina Ummenhofer , Silvia Koch , Nikolay Tzaribachev , Anja Bialkowski and Susanne M Benseler Abstract Introduction: Muckle-Wells syndrome (MWS) is an inherited autoinflammatory disease characterized by fever, rash, arthralgia, conjunctivitis, sensorineural deafness and potentially life-threatening amyloidosis. The NLRP3/CIAS1 E311K mutation caused a heterogeneous phenotype of MWS in a large family. This study analyzes the clinical spectrum, patterns of inflammatory parameters and reports on response to treatment. Methods: A total of 42 patients and family members were screened for the presence of the NLRP3 mutation. Clinical symptoms were reviewed in all family members. Classical (erythrocyte sedimentation rate (ESR, C-reactive protein (CRP)) and novel MWS inflammatory markers (serum amyloid A (SAA), cytokines, cytokine receptor levels) were determined. Patients were treated with the IL-1 inhibitors Anakinra or Canakinumab. Results: All 13 clinically affected patients were heterozygous carriers of the amino acid substitution p.Glu311Lys/ E311K encoded by exon 3 of the NLRP3 gene, but none of the healthy family members. Disease manifestations varied widely. Except for one child, all carriers suffered from h

您可能关注的文档

文档评论(0)

118zhuanqian + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档